New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 6, 2012
18:26 EDTSWHC, GEO, BAGL, SQNM, CMTL, PANW, ALOG, AMRN, QREOn The Fly: After Hours Movers
UP AFTER EARNINGS: Smith & Wesson (SWHC), up 3% after reporting earnings and raising guidance... ALSO HIGHER: Geo Group (GEO), up 6% after declaring a $5.68 special dividend... Noah Einstein (BAGL), up 4% after declaring a $4.00 special dividend... Sequenom (SQNM), up 4% after being issued a sequencing patent... DOWN AFTER EARNINGS: Comtech Telecommunications (CMTL), down 10%... Palo Alto Networks (PANW), down 3%... Analogic (ALOG), down 7%... ALSO LOWER: Amarin (AMRN), down 21% after announcing continued preparations to commercialize Vascepa... QR Energy (QRE), down 4% after announcing an offering of 12M common units.
News For SWHC;GEO;BAGL;SQNM;CMTL;PANW;ALOG;AMRN;QRE From The Last 14 Days
Check below for free stories on SWHC;GEO;BAGL;SQNM;CMTL;PANW;ALOG;AMRN;QRE the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
May 23, 2013
11:55 EDTAMRNOptions with decreasing implied volatility: AEGR PXP AMRN DSX ACT
Subscribe for More Information
May 22, 2013
11:56 EDTAMRNOptions with decreasing implied volatility: WCRX NTI PXP AMRN BBY
06:07 EDTAMRNAmarin announces patent allowance related to combination of Vascepa, Statin
Amarin announced that the United States Patent and Trademark Office has published notification of a Notice of Allowance for Amarin's U.S. Patent Application Serial Number 13/417,899 titled "Pharmaceutical Compositions Comprising EPA and a Cardiovascular Agent and Methods of Using the Same." This application includes claims intended to protect the Vascepa indication approved by the FDA based on Amarin's MARINE clinical trial results specifically those results seen in patients on statin therapy. The claims in this allowed application cover a method to reduce triglycerides in subjects having a triglyceride level of 500mg/dl to 1500mg/dl who are also receiving statin therapy using an amount of Vascepa effective to reduce triglycerides without substantially increasing low density lipoprotein cholesterol.
May 21, 2013
11:41 EDTAMRNOptions with decreasing implied volatility: SGMO WCRX NTI TSLA AMRN
07:42 EDTALOGStephens to host a field trip
Subscribe for More Information
May 20, 2013
15:04 EDTSWHCSmith & Wesson initiated with a Neutral at Sidoti
Subscribe for More Information
May 17, 2013
14:12 EDTAMRNAmarin shares slip after FDA updates Orange Book
Subscribe for More Information
09:33 EDTGEOAvondale Conviction List changes
Subscribe for More Information
May 16, 2013
10:03 EDTPANWOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
07:41 EDTPANWPalo Alto upgraded at Morgan Stanley
As previously reported, Morgan Stanley upgraded Palo Alto to Overweight from Equal Weight. The analyst said Palo Alto is benefiting from security spending for Next Gen Firewalls and can sustain 35%+ revenue growth. Price target is $65.
06:30 EDTPANWPalo Alto upgraded to Overweight from Equal Weight at Morgan Stanley
Price target is $65.
May 15, 2013
11:04 EDTAMRNAmarin management to meet with Lazard Capital
Meeting to be held in the Mid-Atlantic area on May 16 hosted by Lazard Capital.
07:37 EDTGEOMacquarie to host a conference
Subscribe for More Information
May 14, 2013
07:26 EDTSWHCSociety of Manufacturing Engineers to host a conference
Subscribe for More Information
May 13, 2013
16:20 EDTALOGAnalogic expects charge of $5M on restructuring plan
Subscribe for More Information
16:16 EDTALOGAnalogic announces restructuring plan
Subscribe for More Information
12:52 EDTAMRNAmarin strength attributed to MassHealth drug list addition
Subscribe for More Information
10:09 EDTSQNMOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
06:28 EDTSQNMSequenom upgraded to Neutral from Underperform at Credit Suisse
Subscribe for More Information
May 10, 2013
12:31 EDTSQNMOn The Fly: Midday Wrap
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.